• About Us
  • Strategy
  • Our Team
  • Portfolio
  • News
  • Contact
  • Katherine Relle

    uri-geiger

    Dr. Uri Geiger

    Managing Partner

    X Icon

    Managing Partner

    Dr. Uri Geiger

    Connect:

    Linkedin

    Uri Geiger brings extensive entrepreneurial, management and investment know-how, having created and built many successful medical device enterprises.

    Prior to founding Accelmed, Dr. Geiger founded served as CEO of Exalenz Bioscience Ltd. (TASE:EXEN), developer of an innovative breath-based technology for diagnosing liver and gastrointestinal disorders which Dr. Geiger took public in 2007 and later sold to Meridian (NASDAQ: VIVO). Prior to Exalenz, Dr. Geiger co-founded and was the CEO of GalayOr Networks, a developer of optical components, sold in 2003 to MEMSCAP (EuroNext: MEMS). Dr. Geiger is also the founding partner of Dragon Variation Fund, one of Israel’s first hedge funds, which was sold to Migdal in 2007. Dr. Geiger worked on Wall Street during the 1990s, where he gained a broad understanding of capital markets and significant experience, which he put to use after returning to Israel in 1999.

    Dr. Geiger was formerly an adjunct professor at the Recanati Business School at Tel Aviv University, where he lectured on private equity and venture capital. He is the author of the books: Startup Companies and Venture Capital (Tel Aviv University Press, 2001) and From Concept to Wall Street (Financial Times – Prentice Hall, 2003). He earned his doctorate from New York’s Columbia University Center for Law & Economics, where he majored in global equity markets. Dr. Geiger served as a major in the Israeli Air Force.

    eric-tansky

    Eric Tansky

    General Partner

    X Icon

    General Partner

    Eric Tansky

    Connect:

    Linkedin

    Eric was formerly Managing Director and head of Oppenheimer & Co.’s Medical Technology practice. Eric has extensive experience working in the Medical Technology field, covering medical devices, tools, diagnostics and digital health for >20 years as both an investment banker and industry operator. As a banker, Eric worked at both bulge bracket and middle-market firms and completed nearly 100 transactions with >$65 billion of aggregate deal value. Eric’s transaction experience covers various M&A and financing advisory assignments for a broad range of clients from large-cap to development stage companies. Prior to his career in investment banking, Eric spent several years as an OR-based orthopedic craniomaxillofacial sales consultant in the New York area where he spent over 2,000 hours in the OR and gained a front-line appreciation for the challenges companies face marketing products and services in the U.S. healthcare system. Eric also served in the U.S. Navy as a Submarine Officer and Navy Diver after graduating from the U.S. Naval Academy as a Distinguished Graduate and winner of the Brainard Award with a BS in Weapons System Engineering. Eric also received an MBA from Columbia Business School.

    lior-shav

    Lior Shav

    General Partner

    X Icon

    General Partner

    Lior Shav

    Connect:

    Linkedin

    Lior Shav is a General Partner at Accelmed where he focuses primarily on buyout transactions. Lior has over 20 years of experience in business development, investment banking and consulting, primarily in the healthcare space including M&A deals, private placements, private equity transactions, PIPEs and other financial transactions. Prior to joining Accelmed, Lior served in a number of business Development roles and established and managed Shav Consulting, an Israeli healthcare business consulting firm. Prior to that, Lior managed the corporate finance activity of Meitav Capital Markets and served as an analyst in Meitav Corporate Finance Consultant, both subsidiaries of Meitav, one of Israel largest investment management groups. Lior was a co-founder of ETView Ltd. (TASE listed, MedTech company sold in 2016 to Ambu) as well as two other startups. Mr. Shav earned a B.Sc. in Industrial Engineering & Management from the Technion-Israel Institute of Technology in 2001 and a M.A. in Political Science from Tel Aviv University in 2005.

    steve-rubin

    Stephen Rubin

    Partner

    X Icon

    Partner

    Stephen Rubin

    Connect:

    Linkedin

    Steve joins Accelmed from Proskauer, where he was previously co-head of the Private Equity Group. Steve spent more than 30 years in private equity and has been involved in all types of acquisition transactions including auctions and privately negotiated transactions, acquisitions from public and private companies, and acquisitions out of bankruptcy. He has extensive experience in private equity and debt offerings, as well as senior and subordinated loan transactions. Steve is also the former President of the Friends of the Israel Defense Forces (FIDF). Steve holds a J.D. degree from Columbia University School of Law and a B.S. from Cornell University.

    guy-ohad

    Dr. Guy Ohad, M.D.

    Chief Medical Officer

    X Icon

    Chief Medical Officer

    Dr. Guy Ohad, M.D.

    Connect:

    Linkedin

    Dr. Guy Ohad is a radiologist with extensive experience in across both the technology and medical devices sectors. Most recently, he was CEO at POP Medical Solutions (now FEMSelect), a women’s health company developing a minimally invasive device for the treatment of pelvic organ prolapse. Prior to POP, he was Vice President of Clinical and Business Development for the CR product line at Orex, a CSH company (formerly Kodak). In addition, he served as a consultant to several medical device companies and as a clinical advisor to Medica VC. Dr. Ohad holds an M.D. from Tel Aviv University.

    peter-tortora-2

    Dr. Susan Alpert, M.D., Ph.D.

    Chief Regulatory Officer

    X Icon

    Chief Regulatory Officer

    Dr. Susan Alpert, M.D., Ph.D.

    Connect:

    Linkedin

    Dr. Alpert began working with Accelmed in 2011. Previously, she had served as Corporate Senior Vice President for Global Regulatory Affairs at Medtronic and Vice President of Regulatory Science at C.R. Bard. Prior to entering private industry, Dr. Alpert held a variety of management positions at the US FDA covering drugs, devices and radiological health, and foods. Notably, Dr. Alpert was Director of the Office of Device Evaluation from 1993-1999. Susan remains a member and was formerly Chair of the Board of the Society for Women’s Health Research, and has also served on the Board of the Food Drug Law Institute, the Medical Technology Leadership Forum, and Women Business Leaders of the U.S. Health Care Industry Foundation (WBL). She is also a Fellow and former Chair of the Regulatory Affairs Professional Society. Susan served on the Executive Committee of the Clinical Trials Transformation Initiative and served two terms on the Board of the Minnesota International Center.

    Dr. Alpert completed her undergraduate degree at Barnard College, Columbia University in New York City, and is a Pediatric Infectious Disease clinician with a Ph.D. in Medical Microbiology from NYU and an M.D. from the University of Miami, who has practical experience in laboratory research and clinical trials.

    irit-yaniv

    Dr. Irit Yaniv, M.D.

    Partner, Accelmed Ventures

    X Icon

    Partner, Accelmed Ventures

    Dr. Irit Yaniv, M.D.

    Connect:

    Linkedin

    Dr. Irit Yaniv is an experienced HealthTech investor and executive. She plays an important role in leading Accelmed Ventures' portfolio companies, serving either as Chairperson or as an active board member. She is a co-founder of Digma Medical and NitiNotes.

    In addition to Managing Accelmed's Venture fund, Dr. Yaniv is the CEO and Co-Founder of Almeda Ventures. Dr. Yaniv holds an MD degree from the Ben-Gurion University and an MBA from the Recanati Business School at Tel Aviv University.

    ilan-ben-oren

    Ilan Ben-Oren

    Chief Technology Officer

    X Icon

    Chief Technology Officer

    Ilan Ben-Oren

    Connect:

    Linkedin

    Ilan Ben Oren brings more than 20 years’ experience in R&D and management in the medical technology sector. Prior to joining Accelmed, he served as the CTO of Exalenz Bioscience, (TASE:EXEN), developer of an innovative breath-based technology for diagnosing liver and gastrointestinal disorders. Prior to that, he held various positions from project manager to CTO at Oridion Medical (SWX:ORIDN). Mr. Ben-Oren is author of more than 35 patents and patent applications. He holds a Master's degree with special honors, Summa Cum Laude, in Applied Physics and the Science of Materials from the Hebrew University, Jerusalem.

    john-gillings

    John Gillings

    Vice President

    X Icon

    Vice President

    John Gillings

    Connect:

    Linkedin

    John joined Accelmed Partners in 2019, bringing more than 10 years of finance and investment analysis experience in HealthTech. Prior to Accelmed, John established and ran the internal Investor Relations function for Apollo Endosurgery and, prior to that, spent roughly nine years in equity research with Deutsche Bank, Collins Stewart and JMP Securities focused solely on the HealthTech space. His research coverage spanned a broad range of disease states and device types and included large multi-national organizations as well as earlier-stage companies with novel technologies. Prior to business school, he spent time in audit, corporate accounting and investment banking. John holds Bachelors and Masters degrees in Accounting from the University of Utah and a Masters in Finance from London Business School.

    katherine-relle

    Katherine Relle

    Vice President

    X Icon

    Vice President

    Katherine Relle

    Connect:

    Linkedin

    Katherine Relle joined Accelmed as a Vice President in 2021. Prior to Accelmed, she served as a Portfolio Manager within the J.P. Morgan Private Equity Group, sitting on the investment committee and helping to oversee approximately $28 billion in assets under management. Katherine began her career with J.P. Morgan Asset Management, serving in various roles across J.P. Morgan’s Wealth Management and Corporate Strategy teams. Katherine also worked directly with the JPMorgan Chase & Co. operating committee to co-chair the bank’s ‘Women on the Move’ and ‘NextGen’ diversity & inclusion programs. Katherine holds a B.A., magna cum laude, from Georgetown University, an M.Sc. from the London School of Economics, and an M.B.A. from Columbia Business School.

    peter-tortora

    Peter Tortora

    Associate

    X Icon

    Associate

    Peter Tortora

    Connect:

    Linkedin

    Peter Tortora joined Accelmed Partners as an Associate in 2020. Prior to joining Accelmed, Peter was an investment banking analyst at Needham & Company, where he worked on a number of M&A and financing transactions across the healthcare and technology sectors. Peter holds a B.A. in Political Science from Yale University.